It was reported that the device was used for trans-facial sutures with superior and inferior midline fixation points and 3 lateral fixation points.No perioperative bleeding was noted was reported.However, the patient had to returned to theatre post operatively to control bleeding into the rectus muscle.The surgeon believes the bleeding was due to using the reverdin novapass for the transfascial sutures.Questions were asked about the patient and the event.At this time, no further details regarding the patient or event have been provided.
|
Investigation - evaluation: a review of the complaint history, documentation, instructions for use (ifu), and quality control was conducted during the investigation.The complaint device was not returned; therefore, no physical examinations could be performed; however, a document based investigation evaluation was performed.There is no evidence to suggest the product was not made to specifications.The lot number of the device is not known; accordingly, a review of the device history record could not be conducted.The device is shipped with instruction for use (ifu) which notes: "exercise extreme caution during use of this device to avoid unintentional puncture/perforation of vessel, never, bowel, or any other internal organs or vital anatomical structures.¿ also, ¿do not use suture passer in a procedure where the position of the needle tip cannot be clearly identified.¿ clinical assessment cannot eliminate any possible causes for this event such as product handling, medical procedure, patient physiology, device failure, or manufacturing related causes.Based on the information provided, no product returned and the results of our investigation, a definitive root cause could not be determined.We will continue to monitor for similar complaints.Per the quality engineering risk assessment no further action is required.
|